initiation
-
Sports Medicine
Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds
COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat…
Read More » -
Hospitals
VEXIM Initiates International Clinical Study
Toulouse, 4th June 2015 – VEXIM (FR0011072602 – ALVXM / EligiblePEA-PME), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announced the initiation of a…
Read More »